122 related articles for article (PubMed ID: 7174663)
1. Mechanism of the cytostatic activity of 3-deazaaristeromycin, an inhibitor of adenosylhomocysteine hydrolase.
Kim IK; Aksamit RR; Cantoni GL
J Biol Chem; 1982 Dec; 257(24):14726-9. PubMed ID: 7174663
[TBL] [Abstract][Full Text] [Related]
2. Effects of the S-adenosylhomocysteine hydrolase inhibitors 3-deazaadenosine and 3-deazaaristeromycin on RNA methylation and synthesis.
Backlund PS; Carotti D; Cantoni GL
Eur J Biochem; 1986 Oct; 160(2):245-51. PubMed ID: 3769925
[TBL] [Abstract][Full Text] [Related]
3. Basis for resistance to 3-deazaaristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase, in human B-lymphoblasts.
Greenberg ML; Chaffee S; Hershfield MS
J Biol Chem; 1989 Jan; 264(2):795-803. PubMed ID: 2783419
[TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of a murine lymphoid cell line partially deficient in S-adenosylhomocysteine hydrolase.
Kamatani N; Willis EH; Carson DA
Biochim Biophys Acta; 1983 Apr; 762(2):205-14. PubMed ID: 6600937
[TBL] [Abstract][Full Text] [Related]
5. Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells.
Djurhuus R; Svardal AM; Ueland PM
Cancer Res; 1989 Jan; 49(2):324-30. PubMed ID: 2910451
[TBL] [Abstract][Full Text] [Related]
6. Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart.
Schrader J; Schütz W; Bardenheuer H
Biochem J; 1981 Apr; 196(1):65-70. PubMed ID: 7306081
[TBL] [Abstract][Full Text] [Related]
7. Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.
Svardal AM; Djurhuus R; Refsum H; Ueland PM
Cancer Res; 1986 Oct; 46(10):5095-100. PubMed ID: 3756867
[TBL] [Abstract][Full Text] [Related]
8. 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60.
Glazer RI; Hartman KD; Knode MC; Richard MM; Chiang PK; Tseng CK; Marquez VE
Biochem Biophys Res Commun; 1986 Mar; 135(2):688-94. PubMed ID: 3457563
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.
Hasobe M; McKee JG; Ishii H; Cools M; Borchardt RT; De Clercq E
Mol Pharmacol; 1989 Sep; 36(3):490-6. PubMed ID: 2779528
[TBL] [Abstract][Full Text] [Related]
10. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
Palella TD; Schatz RA; Wilens TE; Fox IH
J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
[TBL] [Abstract][Full Text] [Related]
11. Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia.
Achterberg PW; de Tombe PP; Harmsen E; de Jong JW
Biochim Biophys Acta; 1985 Jul; 840(3):393-400. PubMed ID: 4005294
[TBL] [Abstract][Full Text] [Related]
12. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
Hasobe M; Mckee JG; Borcherding DR; Keller BT; Borchardt RT
Mol Pharmacol; 1988 Jun; 33(6):713-20. PubMed ID: 2454388
[TBL] [Abstract][Full Text] [Related]
13. 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells.
Glazer RI; Knode MC; Tseng CK; Haines DR; Marquez VE
Biochem Pharmacol; 1986 Dec; 35(24):4523-7. PubMed ID: 3790170
[TBL] [Abstract][Full Text] [Related]
14. Induction of HL-60 cell differentiation by 3-deaza-(+/-)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase.
Aarbakke J; Miura GA; Prytz PS; Bessesen A; Slørdal L; Gordon RK; Chiang PK
Cancer Res; 1986 Nov; 46(11):5469-72. PubMed ID: 3463413
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolase.
De Clercq E; Cools M; Balzarini J
Biochem Pharmacol; 1989 Jun; 38(11):1771-8. PubMed ID: 2735935
[TBL] [Abstract][Full Text] [Related]
16. 4'-Thioadenosine as a novel inhibitor of S-adenosylhomocysteine hydrolase and an inducer for the differentiation of HL-60 human leukemia cells.
Miura GA; Gordon RK; Montgomery JA; Chiang PK
Adv Exp Med Biol; 1986; 195 Pt B():667-72. PubMed ID: 3464165
[No Abstract] [Full Text] [Related]
17. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase.
Wolos JA; Frondorf KA; Davis GF; Jarvi ET; McCarthy JR; Bowlin TL
J Immunol; 1993 Apr; 150(8 Pt 1):3264-73. PubMed ID: 8468468
[TBL] [Abstract][Full Text] [Related]
18. The bis(adenosin-N6-yl) alkanes, a family of potential dinucleoside polyphosphate analogue precursors. Mechanism of growth inhibition and suppression of adenosine toxicity in lymphoid cells.
Chen H; McLennan AG
Eur J Biochem; 1993 Jul; 215(2):465-71. PubMed ID: 8344314
[TBL] [Abstract][Full Text] [Related]
19. Z-4',5'-didehydro-5'-deoxy-5'-fluoroadenosine (MDL 28,842), an irreversible inhibitor of S-adenosylhomocysteine hydrolase, suppresses proliferation of cultured keratinocytes and squamous carcinoma cell lines.
Paller AS; Arnsmeier SL; Clark SH; Mirkin BL
Cancer Res; 1993 Dec; 53(24):6058-60. PubMed ID: 8261422
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase.
Ueland PM
Pharmacol Rev; 1982 Sep; 34(3):223-53. PubMed ID: 6760211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
